Submit a Story!
Procter & Gamble (PG) – a reliable dividend aristocrat
One company, which, despite the current financial meltdown, continues business as usual, is Procter & Gamble. Other companies which show their confidence in their ability to grow earnings and generate enough cash in the future include Enterprise Products Partners L.P. (EPD), H.B. Fuller ...
Procter and Gamble -- Dividends Talk
risingdividendinvesting.blogspot.com — Procter and Gamble announced late Tuesday that they were hiking their dividend by 10%. This increase was nearly twice what many analysts were estimating and offers important clues about PG's view of the current economy. Here's the reason: Dividends ... (more) Procter and Gamble -- Dividends Talk
Comments
Blog Reactions

Top Stories of the Week at Value Investing News
Fat Pitch Financials — ... and why it is cheap even now without the merger. A high LBO target. For Value Investors, Smaller Is Better Value investors are always looking for inefficiently priced stocks. Such stocks are often found among smaller cap issues, since these securities are not worth the time and the effort of analysts and institutions catering to billion dollar funds. Empirical evidence also supports the fact that small caps have the potential for greater returns… Procter & Gamble (PG) – a reliable dividend aristocrat One company, which, despite the ...

Related Content
Procter & Gamble (PG) Dividend Stock Analysis
valueinvestingnews.com 1/31/2009 — Procter & Gamble is a dividend aristocrat as well as a component of the S&P 500 index. One of its most prominent investors includes the legendary Warren Buffett. Procter & Gamble has been increasing its dividends for the past 52 ...
Stock Analysis: Procter & Gamble Co. (PG)
thediv-net.com 1/5/2009 — The Procter & Gamble Company (P&G) is focused on providing branded consumer goods products. The Company markets its products in more than 180 countries. Linked here is a detailed analysis and commentary.
Stock Analysis: Procter & Gamble Co. (PG)
valueinvestingnews.com 1/10/2009 — The Procter & Gamble Company (P&G) is focused on providing branded consumer goods products. The Company markets its products in more than 180 countries. Linked here is a detailed analysis and commentary.
Procter & Gamble (PG) Increases Dividend 10%
dividendsvalue.com 4/17/2009 — If you closely follow the daily financial news, it is easy become jaded and start believing that there isn’t any good news good news out there. Don’t be confused by the noise. There are still great companies committed to generating superior returns and rewarding their ...
Comment on The Procter & Gamble Company (PG) by alphabetical movie list
wallstrip.com 3/21/2009 — yixjn http://karlito.qsh.eu/alienatied/map.html all night long
Procter & Gamble Co. (PG) Dividend Stock Analysis
dividendsvalue.com 7/27/2009 — This article originally appeared on The DIV-Net July 20, 2009. Linked here is a detailed quantitative analysis of Procter & Gamble Co. (PG). Below are some highlights from the above linked analysis: Company Description: The Procter & Gamble Company (PG) is focused on ...
Procter and Gamble Is Not Much of a Gamble
risingdividendinvesting.blogspot.com 11/8/2008 — By Mike Hull, President Portfolio Mgr. and Greg Donaldson Director of Portfolio Strategy Nearly 15 years ago Mike Hull oversaw the building of a plant for a Fortune 500 company in China and was instrumental in marketing the firm's nutritional ...
Warner Chilcott to Buy Procter & Gamble Unit
dealbook.blogs.nytimes.com 8/24/2009 — Warner Chilcott has agreed to buy Procter & Gamble's prescription drug business, people briefed on the matter told DealBook on Sunday.
PG&E expands solar power plans
sfgate.com 5/14/2009 — BrightSource Energy of Oakland will build the plants in the Southern California desert and sell the power to PG for an undisclosed amount of money. Fields of mirrors at each plant will focus sunlight on centralized towers, boiling water within the ...
P&G Sells Drug Unit for $3.1 Billion
dealbook.blogs.nytimes.com 8/24/2009 — Procter & Gamble said Monday that it agreed to sell its pharmaceuticals unit to Warner Chilcott for $3.1 billion in cash, as P&G seeks to focus on its consumer health and personal care businesses.